In partnership with the Gavi Vaccine Alliance’s Market Shaping team, our new global award will assess the advantages, obstacles, and expediency of using barcode technology in low-and middle-income nations to enhance supply chain transparency and accountability from the first to last mile.
“Barcode innovation has the prospective to be a video game changer for public health supply chains, enhancing accountability and client safety. We are excited to partner with Gavi to explore the complete potential of this technology and share learnings with the international supply chain neighborhood.” Edward Wilson, Director, Center for Health Logistics, JSI.
As worldwide supply chains for medical products become more fragmented, oversight and accountability end up being more complex and challenging, especially in low resourced environments such as low- and middle-income nations. Executing traceability technologies such as barcoding can decrease a few of these risks and reinforce transparency in supply chain operations.
JSI will accelerate Gavi’s The Vaccine Innovation Prioritisation Method (VIPS) by recognizing the potential advantages of using barcodes on vaccines. Specifically, we will validate the identified use cases at nation level and perform feasibility and risk assessments to identify country preparedness to embrace barcoding technologies on vaccines.
This activity constructs on JSI’s more than 30 years of experience improving immunization protection and enhancing supply chains. For additional information about this work, please contact Omar Balsara.